Today: 30 April 2026

Shan Ahmed Khan

As a journalist focused on finance and the stock market, he delivers fast, reliable, and easy-to-understand coverage of market news.

Palantir (PLTR) stock slides 5.6% as insider sale notice surfaces — what to watch next week

Palantir (PLTR) stock slides 5.6% as insider sale notice surfaces — what to watch next week

Palantir shares fell 5.6% to $167.86 Friday, their first 2026 session, after an SEC filing showed officer Ryan D. Taylor plans to sell up to 12,000 shares under a 10b5-1 plan. The stock swung from an early high near $183 to a low around $166. Markets reopen Monday with U.S. jobs and inflation data due next week. Palantir’s next earnings report is expected in early February.
4 January 2026
Establishment Labs (ESTA) stock drops 5.5% — what to watch before Monday’s open and JPM conference

Establishment Labs (ESTA) stock drops 5.5% — what to watch before Monday’s open and JPM conference

Establishment Labs shares fell 5.5% to $68.84 Friday, underperforming a flat Nasdaq. The company recently submitted its Motiva implants to the FDA for breast reconstruction approval. Management will present at the J.P. Morgan Healthcare Conference on Jan. 14. Establishment Labs posted a 2024 net loss of about $85 million on $166 million in revenue.
Via Transportation stock sinks to 52-week low territory after 6% Friday slide — what to watch next for NYSE:VIA

Via Transportation stock sinks to 52-week low territory after 6% Friday slide — what to watch next for NYSE:VIA

Via Transportation shares fell 6.3% Friday to $27.18, near their 52-week low and about 41% below the company’s $46 IPO price from September. The drop came as the S&P 500 rose and mobility peers Uber and Lyft gained. Investors await key U.S. jobs and inflation data next week. Via remains unprofitable and faces risks from public-sector spending and regulatory challenges.
4 January 2026
Wave Life Sciences (WVE) stock slides 6% — what traders are watching next

Wave Life Sciences (WVE) stock slides 6% — what traders are watching next

Wave Life Sciences shares fell 6.2% to $15.95 Friday, underperforming the flat Nasdaq Biotechnology Index. The company expects more Phase 1 obesity trial data in Q1 2026. A December SEC filing said Wave’s equity raise, including over-allotments, was expected to bring in about $402.5 million. Early data showed WVE-007 reduced visceral fat by 9.4% at three months in a 32-person cohort.
4 January 2026
Exzeo Group (XZO) stock drops 6% into weekend — what investors are watching next

Exzeo Group (XZO) stock drops 6% into weekend — what investors are watching next

Exzeo shares fell 6.1% to $22.76 Friday, with trading volume jumping to 424,000 shares from 240,000 the previous session. The stock touched a low of $22.19 and a high of $24.49 during the day. Exzeo’s next earnings report is due Feb. 25. HCI Group, which owns 81.5% of Exzeo, disclosed its CEO Paresh Patel adopted a plan to buy up to 100,000 shares if prices drop further.
4 January 2026
Kymera Therapeutics stock extends slide as KYMR closes down 6.5% — what investors watch next

Kymera Therapeutics stock extends slide as KYMR closes down 6.5% — what investors watch next

Kymera Therapeutics shares fell 6.5% to $72.76 on Friday, marking a seventh straight daily loss and leaving the stock down 29% from its early December peak. About 854,000 shares traded as investors shifted focus to 2026 trial milestones and funding. CEO Nello Mainolfi sold 30,000 shares in a pre-arranged plan on Dec. 31. The company raised $602 million in a December stock offering at $86 per share.
4 January 2026
Guidewire Software stock slides 6.7% into weekend; what GWRE investors watch next

Guidewire Software stock slides 6.7% into weekend; what GWRE investors watch next

Guidewire Software shares fell 6.7% to $187.63 on Friday, closing below key moving averages after a quiet news period. The stock’s 14-day RSI neared 30, signaling oversold conditions, as investors awaited U.S. jobs data and Guidewire’s next earnings in March. About 806,660 shares traded in a session marked by light volume. Guidewire last reported Q1 revenue of $332.6 million and raised its fiscal-year outlook in December.
4 January 2026
BILL stock slides 7% to start 2026 despite KBW target raise — what to watch Monday

BILL stock slides 7% to start 2026 despite KBW target raise — what to watch Monday

BILL Holdings shares fell 7.3% to $50.56 Friday, marking one of their steepest single-day drops in weeks. Keefe, Bruyette & Woods raised its price target to $60 but maintained a “market perform” rating. The decline came as the S&P 500 rose 0.19% and the Nasdaq was flat. BILL’s next key events include a Jan. 16 finance leadership change and an earnings update expected in early February.
1 307 308 309 310 311 584

Stock Market Today

  • 3 TSX Dividend Stocks for Passive Income: Peyto, Advantage Energy, Whitecap
    April 29, 2026, 8:58 PM EDT. Peyto (TSX:PEY), Advantage Energy (TSX:AAV), and Whitecap Resources (TSX:WCP) stand out among TSX stocks offering dividend income potential. Peyto's monthly payouts are supported by rising production and reduced debt, trading at a reasonable price-to-earnings ratio near 11.8. Advantage Energy sees record production and rising funds flow but lacks a consistent dividend, making it a riskier income choice with a higher P/E of 30. Whitecap Resources offers a monthly dividend with a larger operating base after integrating the Veren acquisition. All focus on natural gas and liquids production mainly in Alberta, each balancing yield sustainability and operational resilience amid commodity price fluctuations.

Latest article

Soluna Holdings Stock Jumps After Sazmining Bitcoin Deal, Then SEC Resale Filing Lands

Soluna Holdings Stock Jumps After Sazmining Bitcoin Deal, Then SEC Resale Filing Lands

30 April 2026
Soluna Holdings filed to register the resale of about 2.46 million common shares, with no proceeds going to the company. The move follows Sazmining’s launch of a 3-megawatt Bitcoin mining operation at Soluna’s Project Dorothy 1B in West Texas. Soluna shares last traded at $1.28, up from a $1.08 Nasdaq sale price on April 28. The registered shares include 2.4 million issuable to YA II PN, LTD. via warrant exercise.
Brookfield Renewable Stock Drops 12% Before Q1 Results as BEPC Investors Brace for Friday

Brookfield Renewable Stock Drops 12% Before Q1 Results as BEPC Investors Brace for Friday

30 April 2026
Brookfield Renewable Corp’s NYSE shares fell 12.5% to $35.20 on Wednesday, with volume quadrupling the three-month average ahead of first-quarter results due Friday. The drop came despite a higher quarterly dividend and mixed analyst views. The company operates 47 GW of clean energy assets globally. Analysts expect a first-quarter loss of 33.92 cents per share on $1.62 billion in revenue.
Go toTop